MEI Pharma, Inc(NASDAQ:MEIP) 
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase II clinical trial for the treatment of patients with relapsed/re...
Website: http://www.meipharma.com
Founded: 2000
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-13
P
O 2.34
H 2.35
L 2.30
C 2.30
V 4,929
10EMA 2.30
20EMA 2.30
60EMA 2.30
120EMA 2.30
250EMA 2.30